[1] Richman DD, Margolis DM, Delaney M, et al. The challenge of finding a cure for HIV infection[J] . Science, 2009, 323(5919):1304-1307. [2] Excler JL, Robb ML, Kim JH. Prospects for a gGlobally effective HIV-1 vaccine[J] . Am J Prev Med, 2015, 49(6 Suppl 4):S307-318. [3] Smaglik P. AIDS vaccine researchers turn from chimps to monkeys[J] . The Scientist, 1999, 13(16):7-9. [4] Antony JM, MacDonald KS. A critical analysis of the cynomolgus macaque, Macaca fascicularis, as a model to test HIV-1/SIVvaccine efficacy[J] . Vaccine, 2015, 33(27):3073-3083. [5] Friedrich BM, Dziuba N, Li G, et al. Host factors mediating HIV-1 replication[J] . Virus Res, 2011, 161(2):101-114. [6] Malim MH, Bieniasz PD. HIV restriction factors and mechanisms of evasion[J] . Cold Spring Harb Perspect Med, 2012, 2(5):a006940. [7] Sauter D. Counteraction of the multifunctional restriction factor tetherin[J] . Front Microbiol, 2014, 5:163. [8] Newman RM, Hall L, Connole M, et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha[J] . Proc Natl Acad Sci USA, 2006, 103(50):19134-19139. [9] Puvvada MP, Patel SS. Role of trim5α in the suppression of cross-species transmission and its defence against human immunodefici-ency virus[J] . Curr HIV Res, 2013, 11(8):601-609. [10] Sakuma R, Mael AA, Ikeda Y. Alpha interferon enhances TRIM5-alpha-mediated antiviral activities in human and rhesus monkey cells[J] . J Virol, 2007, 81(18):10201-10206. [11] Sastri J, Johnsen L, Smolin N, et al. Restriction of HIV-1 by rhe-sus TRIM5α is governed by alpha helices in the Linker2 region[J] . J Virol, 2014, 88(16):8911-8923. [12] Li X, Kim J, Song B, et al. Virus-specific effects of TRIM5α(rh)RING domain functions on restriction of retroviruses[J] . J Virol, 2013, 87(13):7234-7245. [13] Lukic Z, Goff SP, Campbell EM, et al. Role of SUMO-1 and SUMO interaction motifs in rhesus TRIM5α-mediated restriction[J] . Retrovirology, 2013, 10:10. [14] Brandariz-Nu?ez A, Roa A, Valle-Casuso JC, et al. Contribution of SUMO- interacting motifs and SUMOylation to the antiretroviral properties of TRIM5α[J] . Virology, 2013, 435(2):463-471. [15] Mussolino C, Alzubi J, Fine EJ, et al. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity[J] . Nucleic Acids Res, 2014, 42(10):6762-6773. [16] Lascano J, Uchil PD, Mothes W, et al. TRIM5 retroviral restriction activity correlates with the ability to induce innate immune signaling[J] . J Virol, 2015, 90(1):308-316. [17] Kimura T, Jain A, Choi SW, et al. TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity[J] . J Cell Biol, 2015, 210(6):973-989.
|